“…Hydrazine-1-carbothioamide (3-thiosemicarbazide) derivatives received considerable attention owing to their diverse chemotherapeutic activities [ 1 ]. Several mono- and di-substituted- N -hydrazine-1-carbothioamides were reported to possess marked anticancer [ 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ], antifungal [ 10 , 11 , 12 ], antituberculous [ 13 , 14 , 15 ], antiviral [ 16 , 17 ], antibacterial [ 18 , 19 , 20 , 21 , 22 ], and antiprotozoan activities [ 23 , 24 , 25 , 26 ]. In addition, several hydrazine-1-carbothioamide derivatives were recognized as potent urease inhibitors [ 27 , 28 , 29 , 30 , 31 , 32 ].…”